Bronchial hyperresponsiveness to dry powder mannitol and exercise test in adolescents with asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Prevalence of bronchoconstriction in patients with bronchiectasis assessed prior to treatment with a dry powder preparation of mannitol Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
No differences in bronchodilation after inhalation of dry powder β2 -agonists in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001
Comparison of two dry powder inhalers containing budesonide in the treatment of asthma in children Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
Bronchial provocation tests with dry powder mannitol versus histamine: value for clinical practice and relation to eNO Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009
Effects of nedocromil and salbutamol on airway reactivity in children with asthma Source: Eur Respir J 2002; 20: 624-629 Year: 2002
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006
Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Applicability of dry powder inhalers in children with CF Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Improving inhalation parameters through dry powder inhalers (DPIs) after an acute asthma exacerbation Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Acceptability of two dry powder inhalers in 645 asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Handling and patient preference of dry powder inhalers for asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
Measurement of inspiratory flow through 3 different dry powder inhalation devices using In-check in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001
Efficiency of extrafine beclometasone dipropionat/formoterol fumarate in asthma patients with cold and/or osmotic airway hyperresponsiveness (AHR) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Comparison of validity of methacholine and mannitol bronchial challenges in asthma diagnosis Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Study of mucociliary clearance and peak nasal inspiratory flow rate in children with allergic rhinitis before and after therapy with natural cellulose powder Source: Eur Respir J 2005; 26: Suppl. 49, 401s Year: 2005
One-year height growth in children with asthma treated with inhaled budesonide delivered from a new dry powder inhaler. Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008